RENFOR 180MG TABLET

Renfor 180 mg tablet is an immunosuppressant with an active ingredient known as Mycophenolate sodium. It is part of the inosine-monophosphate dehydrogenase (IMPDH) inhibitor class. The medicine is prescribed to avoid organ rejection in patients who have had one of their organs (such as heart, kidney, or even liver transplantation). It is usually prescribed as part of a combination treatment that includes other immunosuppressive medicines.
This medication is not recommended during pregnancy because of the risk of miscarriage and congenital disabilities. This medication should not be used for pregnant women unless there are no other suitable alternatives and the possible benefits outweigh any risks. Women who are prone to conceive are strongly advised to utilize the most effective contraception available while taking this tablet to avoid the possibility of pregnancy. Live vaccines shouldn’t be administered when a patient takes Renfor 180mg tablets due to the vaccine’s lower effectiveness and the chance of contracting an infection. Patients taking this medication are not allowed to donate blood during treatment and, at minimum, six weeks after having stopped treatment. This ensures the drug is entirely cleared out of the body before blood donation.
It is recommended not to take this drug when allergic to the medication or other ingredients. Inform your physician if you suffer from heart or liver disease before beginning treatment. Since this medication weakens the body’s immune defenses, it could increase the risk of developing skin cancer. People should take steps to minimize their exposure to the ultraviolet (UV) radiation. Consult your physician immediately when you experience any bleeding on your skin or fever. Unprovoked dizziness, fatigue, eyes, or skin. Eyes or eyes, vision impairment, decreased urine output, or seizures following this medication. Renfor 180 mg tablet is an immunosuppressive drug. It can affect a baby’s developing immune system and is not recommended for breastfeeding mothers.